Table 1.
| Characteristics | Total: N = 59 |
|---|---|
| Gendera | |
| Women | 11 |
| Men | 48 |
| Age (in years)a | |
| Range | 32–83 |
| Mean | 61.3 |
| Women (mean) | 57.6 |
| Men (mean) | 62.1 |
| Symptom duration (in months)a | |
| Range | 0.5–540 |
| Mean | 62.6 |
| Women (mean) | 204.0 |
| Men (mean) | 48.6 |
| Symptoms at presentationa,b | |
| Mass, facial swelling | 17 |
| Obstructive symptoms | 15 |
| Epistaxis | 8 |
| Pain and/or headache | 8 |
| Optic symptoms (proptosis, ptosis, diplopia) | 8 |
| Drainage, discharge, crusting | 6 |
| Nerve changes (paralysis, palsy, paresthesias, numbness, dysphagia, trismus, tingling) | 2 |
| Otic symptoms | 1 |
| Locationa | |
| Mixed (more than one anatomic site) | 38 |
| Maxillary sinus only | 8 |
| Nasal cavity only | 8 |
| Lateralitya | |
| Right | 15 |
| Left | 19 |
| Bilateral | 1 |
| Papilloma type | |
| Inverted | 43 |
| Exophytic | 3 |
| Oncocytic | 13 |
| Carcinoma type | |
| Squamous cell carcinoma (including in situ) | 49 |
| Mucoepidermoid carcinoma | 6 |
| Sinonasal undifferentiated carcinoma | 2 |
| Carcinoma, not otherwise specified | 2 |
| All patients with follow-up (n = 54) (mean years of survival) | |
| Follow-up range | 0.3–15.9 |
| Alive, no evidence of disease (n = 25) | 5.9 |
| Alive, with disease (n = 3) | 2.5 |
| Dead, no evidence of disease (n = 3) | 3.0 |
| Dead, with local disease (n = 14) | 3.5 |
| Dead, with disseminated disease (n = 9) | 1.2 |
| Patients with recurrence (n = 18) | 4.3 |
| Patients without recurrence (n = 36) | 4.1 |
This table does not include the series reported in this study
aParameter was not stated in all cases
bPatients may have experienced more than one symptom